News

Proposed Settlement Announcement in Tricida Securities Case

Proposed Settlement Announcement in Tricida Securities Case

Overview of the Tricida Securities Litigation Settlement

Kroll Settlement Administration is pleased to announce a proposed settlement concerning the class action lawsuit related to Tricida, Inc. This case, known as Pardi v. Tricida, Inc., Case No. 4:21-cv-00076-HSG, is currently being processed in the United States District Court, Northern District of California. If you purchased or acquired Tricida, Inc. common stock from May 8, 2020, to February 25, 2021, you may be eligible to participate in this settlement.

Settlement Details and Fund Allocation

The proposed settlement amounts to $14,250,000 in cash that would be distributed amongst affected shareholders. A hearing is scheduled to evaluate whether this settlement is fair and adequate to the members of the class. The court will assess various components, including the release of claims by class members and the proposed plan for distributing settlement proceeds. Key considerations will include the plan's fairness and the request for attorneys' fees.

Eligibility for Settlement

All persons and entities who purchased Tricida, Inc. common stock during specified dates should be aware that their rights and entitlement to recovery are defined by this litigation. You must submit a Claim Form, along with accompanying documentation, no later than October 1, 2025. Missing this deadline could affect your ability to receive any settlement distribution.

How to Participate in the Claim Process

To participate in the settlement, all qualifying class members must complete their Claim Form properly and submit it in accordance with the guidelines laid out in the notice. This process ensures that they can receive their fair share of the settlement fund.

Class Member Rights and Options

Class members have the option to object to any aspect of the settlement, including the plan for allocating funds and requests for attorney fees. It is vital to adhere to the specified timelines when filing objections to ensure they are considered by the court.

Exclusion from the Class Action

If you prefer not to be part of this class litigation settlement, you have until September 11, 2025, to submit a request for exclusion. Those who do not request exclusion will be bound by the court's judgment in this action.

Contact Information for Inquiries

For further questions regarding the settlement or the claims process, class members may contact Kroll Settlement Administration. They are equipped to provide the necessary assistance regarding the claims process and any additional inquiries members may have.

Frequently Asked Questions

What is the Tricida securities litigation settlement about?

The settlement involves a class action lawsuit related to Tricida, Inc. common stock purchases between specified dates and amounts to $14,250,000.

Who is eligible for the settlement?

Individuals or entities that purchased Tricida, Inc. common stock from May 8, 2020, to February 25, 2021, are eligible for the settlement.

How can I file a claim?

You must complete and return the Claim Form postmarked by October 1, 2025, to qualify for any payment.

What happens if I miss the Claim Form deadline?

Failing to submit the Claim Form by the deadline may result in your claim being rejected, and you may miss out on any settlement recovery.

Can I object to the settlement?

Yes, you may object to the settlement, but you must do so by September 11, 2025, following the specified guidelines.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 59

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 428

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 0

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading

Top 5 Most Recently Viewed Articles

Kalmar Corporation Announces Share Allocation Plan for Key Personnel

Updated Category News Views 107

Share Allocation Based on Kalmar’s Incentive Plans Kalmar Corporation has recently conveyed a significant number of its treasury shares, contributing to the engagement and retention of key personnel within the organization. This allocation is part of the company’s broader strategy to incentivize and reward its dedicated workforce through performance and restricted...

Continue Reading
Mink Ventures Successfully Completes Acquisition of Key Patents

Updated Category News Views 118

Mink Ventures Completes Acquisition of Warren Patents Recently, Mink Ventures Corporation, known by the ticker MINK, proudly announced the successful culmination of its efforts to acquire a 100% interest in the Warren nickel, copper, and cobalt patents through its option agreement with US Copper Corp. This milestone marks a significant step in expanding Mink's exploration...

Continue Reading
Comerica Unveils Dividend Increase and Buyback Plans

Updated Category News Views 34

Comerica Announces Quarterly Cash Dividend Comerica Incorporated (NYSE: CMA) recently declared a quarterly cash dividend of 71 cents per share for its common stock. This dividend will be distributed to shareholders who are on record at the close of business as of the designated cutoff date. The issuance of dividends is a sign of the company's robust financial health and...

Continue Reading
Birkenstock's Growth Projections are Set to Surge in 2025

Updated Category News Views 218

Birkenstock's Revenue Outlook for 2025 Birkenstock Holding plc (NYSE: BIRK) recently saw its shares rise significantly as the iconic footwear company reiterated its optimistic outlook for the upcoming fiscal year. The company's executives have announced expectations for a revenue of at least 2.09 billion euros, which translates to approximately $2.25 billion for fiscal...

Continue Reading
TRREB Welcomes New GTA Cabinet Members and Housing Minister

Updated Category News Views 199

TRREB Welcomes the New Cabinet and Housing Minister The Toronto Regional Real Estate Board (TRREB) extends its heartfelt congratulations to the newly appointed Cabinet members by Prime Minister Mark Carney. Among these appointments, we are particularly pleased with the appointment of Gregor Robertson as Minister of Housing and Infrastructure. Addressing the Housing Supply...

Continue Reading